Compare EML & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EML | RCEL |
|---|---|---|
| Founded | 1858 | N/A |
| Country | United States | United States |
| Employees | N/A | 226 |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 133.9M | 129.3M |
| IPO Year | 1995 | N/A |
| Metric | EML | RCEL |
|---|---|---|
| Price | $21.87 | $4.11 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $7.88 |
| AVG Volume (30 Days) | 16.0K | ★ 270.2K |
| Earning Date | 05-12-2026 | 05-14-2026 |
| Dividend Yield | ★ 1.98% | N/A |
| EPS Growth | ★ 185.40 | N/A |
| EPS | ★ 0.11 | N/A |
| Revenue | ★ $248,970,345.00 | N/A |
| Revenue This Year | $19.05 | $17.17 |
| Revenue Next Year | N/A | $49.82 |
| P/E Ratio | $199.09 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $17.61 | $3.22 |
| 52 Week High | $26.76 | $7.12 |
| Indicator | EML | RCEL |
|---|---|---|
| Relative Strength Index (RSI) | 60.97 | 44.38 |
| Support Level | $21.54 | $4.00 |
| Resistance Level | $22.80 | $5.75 |
| Average True Range (ATR) | 0.48 | 0.30 |
| MACD | 0.09 | -0.02 |
| Stochastic Oscillator | 87.81 | 17.78 |
The Eastern Co manages industrial businesses that design, manufacture, and sell engineered solutions to the industrial market. The company manages the financial, operational, and strategic performance of its businesses to increase cash generation, operating earnings, and long-term shareholder value. It has one reportable segment: Engineered Solutions, which provides engineered solutions mainly for the commercial transportation and logistics markets. This segment offers a diverse product line of custom and standard vehicular and industrial hardware, including turnkey returnable packaging solutions, blow molds, compression latches, draw latches, hinges, camlocksaccess, mirrors, and mirror-cameras, among other products. Geographically, the group derives maximum revenue from the United States.
Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.